August 8, 2018 10:13 AM EDTUpdated 10:40 AM

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure

Brittany Meiling

A tiny Australian biotech that experienced a very public and explosive clinical trial failure is once again in the spotlight — this time, for its ties …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure

Brittany Meiling

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

FDA says Ozempic, Wegovy shortage is over

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

In­sid­er trad­ing in Wash­ing­ton: NY Con­gress­man in­dict­ed for shar­ing in­side biotech tips ahead of mas­sive tri­al fail­ure

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure